4.8 Article

Controlled drug release for tissue engineering

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 219, Issue -, Pages 119-128

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2015.08.049

Keywords

Tissue engineering; Scaffold; Biomaterials; Regenerative medicine; Polymer; Controlled release; Drug delivery

Funding

  1. NIH (NIDCR) [DE022327, DE015384]
  2. DOD [W81XWH-12-2-0008]
  3. NSF [DMR-1206575]
  4. NIH (NHLBI) [HL114038]

Ask authors/readers for more resources

Tissue engineering is often referred to as a three-pronged discipline, with each prong corresponding to 1) a 3D material matrix (scaffold), 2) drugs that act on molecular signaling, and 3) regenerative living cells. Herein we focus on reviewing advances in controlled release of drugs from tissue engineering platforms. This review addresses advances in hydrogels and porous scaffolds that are synthesized from natural materials and synthetic polymers for the purposes of controlled release in tissue engineering. We pay special attention to efforts to reduce the burst release effect and to provide sustained and long-term release. Finally, novel approaches to controlled release are described, including devices that allow for pulsatile and sequential delivery. In addition to recent advances, limitations of current approaches and areas of further research are discussed. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available